Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2006 1
2007 1
2009 2
2011 3
2012 3
2013 3
2014 3
2015 4
2016 2
2017 2
2019 2
2020 3
2021 4
2022 4
2023 4
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

39 results

Results by year

Filters applied: . Clear all
Page 1
Uveal Melanoma Metastasis.
Rossi E, Croce M, Reggiani F, Schinzari G, Ambrosio M, Gangemi R, Tortora G, Pfeffer U, Amaro A. Rossi E, et al. Among authors: gangemi r. Cancers (Basel). 2021 Nov 13;13(22):5684. doi: 10.3390/cancers13225684. Cancers (Basel). 2021. PMID: 34830841 Free PMC article. Review.
The biology of uveal melanoma.
Amaro A, Gangemi R, Piaggio F, Angelini G, Barisione G, Ferrini S, Pfeffer U. Amaro A, et al. Among authors: gangemi r. Cancer Metastasis Rev. 2017 Mar;36(1):109-140. doi: 10.1007/s10555-017-9663-3. Cancer Metastasis Rev. 2017. PMID: 28229253 Free PMC article. Review.
Hyaluronan-Cyclodextrin Conjugates as Doxorubicin Delivery Systems.
Bognanni N, Viale M, La Piana L, Strano S, Gangemi R, Lombardo C, Cambria MT, Vecchio G. Bognanni N, et al. Among authors: gangemi r. Pharmaceutics. 2023 Jan 21;15(2):374. doi: 10.3390/pharmaceutics15020374. Pharmaceutics. 2023. PMID: 36839696 Free PMC article.
How to Make Immunotherapy an Effective Therapeutic Choice for Uveal Melanoma.
Marseglia M, Amaro A, Solari N, Gangemi R, Croce E, Tanda ET, Spagnolo F, Filaci G, Pfeffer U, Croce M. Marseglia M, et al. Among authors: gangemi r. Cancers (Basel). 2021 Apr 23;13(9):2043. doi: 10.3390/cancers13092043. Cancers (Basel). 2021. PMID: 33922591 Free PMC article. Review.
Ataxia-Telangiectasia Mutated Loss of Heterozygosity in Melanoma.
Pastorino L, Dalmasso B, Allavena E, Vanni I, Ugolini F, Baroni G, Croce M, Guadagno A, Cabiddu F, Andreotti V, Bruno W, Zoppoli G, Ferrando L, Tanda ET, Spagnolo F, Menin C, Gangemi R, Massi D, Ghiorzo P. Pastorino L, et al. Among authors: gangemi r. Int J Mol Sci. 2022 Dec 16;23(24):16027. doi: 10.3390/ijms232416027. Int J Mol Sci. 2022. PMID: 36555667 Free PMC article.
Guadecitabine increases response to combined anti-CTLA-4 and anti-PD-1 treatment in mouse melanoma in vivo by controlling T-cells, myeloid derived suppressor and NK cells.
Amaro A, Reggiani F, Fenoglio D, Gangemi R, Tosi A, Parodi A, Banelli B, Rigo V, Mastracci L, Grillo F, Cereghetti A, Tastanova A, Ghosh A, Sallustio F, Emionite L, Daga A, Altosole T, Filaci G, Rosato A, Levesque M, Maio M, Pfeffer U, Croce M; EPigenetic Immune-oncology Consortium Airc (EPICA) consortium. Amaro A, et al. Among authors: gangemi r. J Exp Clin Cancer Res. 2023 Mar 18;42(1):67. doi: 10.1186/s13046-023-02628-x. J Exp Clin Cancer Res. 2023. PMID: 36934257 Free PMC article.
New perspectives in glioma immunotherapy.
Daga A, Bottino C, Castriconi R, Gangemi R, Ferrini S. Daga A, et al. Among authors: gangemi r. Curr Pharm Des. 2011;17(23):2439-67. doi: 10.2174/138161211797249206. Curr Pharm Des. 2011. PMID: 21827420 Review.
39 results